SDF-1 liposomes promote sustained cell proliferation in mouse diabetic wounds

Wound Repair and Regeneration

Volumn 23, Issue 5, 2015, Pages 711-723

  Olekson, Melissa A Przyborowski ^a   Faulknor, Renea ^a   Bandekar, Amey ^a   Sempkowski, Michelle ^a   Hsia, Henry C ^b   Berthiaume, François ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Chemotaxis; Dermis; Diabetes; Growth factors; Liposome; Wound healing

Indexed keywords

CD31 ANTIGEN; LIPOSOME; STROMAL CELL DERIVED FACTOR 1;

ACELLULAR DERMAL MATRIX; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; EXCISION; GRANULATION TISSUE; HL 60 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; THICKNESS; TISSUE ENGINEERING; WOUND HEALING; ANIMAL; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN; TISSUE SCAFFOLD; WOUNDS AND INJURIES;

ACELLULAR DERMIS; ANIMALS; CELL PROLIFERATION; CHEMOKINE CXCL12; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; LIPOSOMES; MICE; SKIN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84945493644     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12334     Document Type: Article

References (37)

1. Chow I, Lemos EV, Einarson TR, Management and prevention of diabetic foot ulcers and infections: A health economic review. Pharmacoeconomics 2008; 26: 1019-35.
2. Greer N, Foman NA, MacDonald R, Dorrlan J, Fitzgerald P, Rutks I, et al., Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers. Ann Intern Med 2013; 59: 532-42.
3. Jean J, Garcia-Pérez ME, Pouliot R., Bioengineered skin: The self-assembly Approach. J Tissue Sci Eng 2011; 5: 1-10.
4. Bello YM, Falabella AF, Eaglstein WH., Tissue engineered skin: Current status in wound healing. Am J Clin Dermatol 2001; 2: 305-13.
5. Huang S, Fu X., Naturally derived materials-based cell and drug delivery systems in skin regeneration. J Control Release 2010; 142: 149-59.
6. Sarkar A, Tatlidede S, Scherer S, Orgill DP, Berthiaume F., Combination of stromal cell-derived factor-1 and collage-glycosaminoglycan scaffold delays wound contraction and accelerates reepithelialization of dermal wounds in wild-type mice. Wound Repair Regen 2011; 19: 71-9.
7. Guo S, Dipietro LA., Factors affecting wound healing. J Dent Res 2010; 89: 219-29.
8. Chin GA, Schultz GS, Chegini N, Diegelmann RF., Biochemistry of wound healing in wound care practice. In:, Sheffield PJ, Fife CE, editors. Wound Care Practice, 2nd ed. North Palm Beach, FL: Best Publishing Co, 2006: 1-28.
9. Dar A, Goichberg V, Shinder A, Kalinkovich O, Kollet N, Netzer R, et al., Chemokine receptor Cxcr4-dependent internalization and resecretion of functional chemokine sdf-1 by bone marrow endothelial stromal cells. Nat Immunol 2005; 6: 1038-46.
10. Lau TT, Wang DA., Stromal cell-derived factor-1 (SDF-1): Homing factor for engineered regenerative medicine. Expert Opin Biol Ther 2011; 11: 189-97.
11. Kuraitis D, Zhang P, Zhang Y, Padavan DT, McEwan K, Sofrenovic T, et al., A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cells Mater 2011; 22: 109-23.
12. Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, de Vries EG, et al., A review on CXCR4/CXCL12 axis in oncology: No place to hide. Eur J Cancer 2013; 49: 219-30.
13. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al., Diabetic impairments in no-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxoa and SDF-1 alpha. J Clin Invest 2007; 117: 1249-59.
14. Restivo TE, Mace KA, Harken AH, Young DM., Application of the chemokine CXCL12 expression plasmid restores healing to near normal in a diabetic mouse model. J Trauma 2010; 69: 392-8.
15. Bandekar A, Karve S, Chang MY, Mu Q, Rotolo J, Sofou S., Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin. Biomaterials 2012; 33: 4345-52.
16. Sofou S, Thomas JL, Lin H, McDevitt MR, Scheinberg DA, Sgouros G., Engineered liposomes for potential alpha-particle therapy of metastatic cancer. J Nucl Med 2004; 45: 253-60.
17. Zheng F, Li H, Du W, Huang S., Role of hERG1 K+ channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation. Hematology 2011; 16: 177-84.
18. Voermans C, Anthony EC, Mul E, van der Schoot E, Hordijk P., SDF-1 induced actin polymerization and migration in human hematopoietic progenitor cells. Exp Hematol 2001; 29: 1456-64.
19. Macri L, Clark RAF., Tissue engineering for cutaneous wounds: Selecting the proper time and space for growth factors, cells, and the extracellular matrix. Skin Pharmacol Phys 2009; 22: 82-93.
20. Cleutjens JP, Verluyten MJ, Smiths JF, Daemen MJ., Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995; 147: 325-38
21. Rich L, Whittaker P., Collagen and picosirius red staining: A polarized light assessment of fibrillar hue and spatial distribution. Braz J Morphol Sci 2005; 22: 97-104.
22. Luo J, Luo Z, Zhou N, Hall J, Huang Z., Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide. Biochem Bioph Res Co 1999; 264: 42-7.
23. Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta NA, Frederick JR, Fitzpatrick JR, et al., Computational protein design to reengineer stromal cell-derived factor 1α generates an effective and translatable angiogenic polypeptide analog. Circulation 2011; 124: S18-26.
24. Yang Y, Shim SK, Kim HA, Seon M, Yang E, Cho D, et al., CXC chemokine receptor 4 is essential for lipo-pge-1-enhanced migration of human dermal fibroblasts. Exp Dermatol 2011; 21: 70-80.
25. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver S, Murasawa M, et al., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322-8.
26. Reilkoff RA, Bucala R, Herzog EL., Fibrocytes: Emerging effector cells in chronic inflammation. Nat Rev Immunol 2011; 11: 427-35.
27. Sadir R, Imberty A, Baleux F, Lortat-Jacob H., Heparin sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004; 279: 43854-60.
28. Salanga CL, Handel TM., Chemokine oligomerization and interactions with receptors and glucosaminoglycans: The role of structural dynamics in function. Exp Cell Res 2011; 317: 590-601.
29. Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, et al., Heparin oligosaccharides inhibit chemocike (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. J Biol Chem 2013; 288: 737-46.
30. Pierre MBR, Costa IDM., Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res 2011; 303: 607-21.
31. Papakostas D, Rancan D, Sterry W, Blume-Peytavi U, Vogt A., Nanoparticles in dermatology. Arch Dermatol Res 2011; 303: 522-50.
32. Roesken F, Uhl S, Curri SB, Menger MD, Messmer K., Acceleration of wound healing by topical drug delivery via liposomes. Langenbeck Arch Surg 2000; 385: 42-9.
33. Wang J, Wan R, Mo Y, Li M, Zhang Q, Chien S., Intracellular delivery of adenosine triphosphate enhanced healing process in full-thickness skin wounds in diabetic rabbits. Am J Surg 2010; 199: 823-32.
34. Wong L, Wang Z, Yang B, Yang Q, Wang L, Sun Y., CXCR4 nuclear localization folllows binding of its ligand SDF-1 and occurs in metastatic but not primary renal carcinoma. Oncol Rep 2009; 22: 1333-9.
35. Lazic T, Falanga V., Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg 2011; 127: 75S-90S.
36. Van der Veen V, van der Waal MBA, van Leeuwen MCE, Ulrich MMW, Middelkoop E., Biological background of dermal substitutes. Burns 2010; 36: 305-21.
37. Soto-Gutierrez A, Wertheim JA, Ott HC, Gilbert TW., Perspectives on whole-organ assembly: Moving toward transplantation on demand. J Clin Invest 2012; 122: 3817-23.